Table of Contents Author Guidelines Submit a Manuscript
International Journal of Rheumatology
Volume 2016, Article ID 7831410, 5 pages
http://dx.doi.org/10.1155/2016/7831410
Research Article

The Diagnostic Value of Alpha-1-Antitrypsin Phenotype in Patients with Granulomatosis with Polyangiitis

1First Pavlov State Medical University of St. Petersburg, Saint Petersburg 197022, Russia
2North-Western Mechnikov State Medical University, Saint Petersburg 191015, Russia

Received 28 January 2016; Revised 9 March 2016; Accepted 27 March 2016

Academic Editor: Ruben Burgos-Vargas

Copyright © 2016 M. Y. Pervakova et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. C. Jennette, R. J. Falk, P. A. Bacon et al., “2012 Revised International Chapel Hill Consensus Conference nomenclature of vasculitides,” Arthritis & Rheumatism, vol. 65, no. 1, pp. 1–11, 2013. View at Google Scholar
  2. M. Bohm, M. I. Gonzalez Fernandez, S. Ozen et al., “Clinical features of childhood granulomatosis with polyangiitis (wegener's granulomatosis),” Pediatric Rheumatology, vol. 12, article 18, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. A. D. Mahr, J. C. Edberg, J. H. Stone et al., “Alpha 1-antitrypsin deficiency-related alleles Z and S and the risk of Wegener's granulomatosis,” Arthritis Care and Research, vol. 62, no. 12, pp. 3760–3767, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. D. E. Jenne, J. Tschopp, J. Lüdemann et al., “Wegener's autoantigen decoded,” Nature, vol. 346, no. 6284, p. 520, 1990. View at Google Scholar
  5. V. Boulyjenkov, “α1-antitrypsin deficiency: memorandum from a WHO meeting,” Bulletin of the World Health Organization, vol. 75, no. 5, pp. 397–415, 1997. View at Google Scholar · View at Scopus
  6. S. Gadre, J. Stoller, and A. Mehta, “Granulomatosis with polyangiitis and associated pulmonary emphysema: breathtaking vasculitis,” Lung India, vol. 32, no. 4, pp. 367–369, 2015. View at Publisher · View at Google Scholar · View at Scopus
  7. D. F. Keren, Ed., Protein Electrophoresis in Clinical Diagnosis, Edward Arnold, London, UK, 2003.
  8. L. Fregonese and J. Stolk, “Hereditary alpha-1-antitrypsin deficiency and its clinical consequences,” Orphanet Journal of Rare Diseases, vol. 3, article 16, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. “American Thoracic Society/European Respiratory Society statement: standards for the diagnosis and management of individuals with alpha-1 antitrypsin deficiency,” American Journal of Respiratory and Critical Care Medicine, vol. 168, no. 7, pp. 818–900, 2003. View at Publisher · View at Google Scholar
  10. T. J. Craig, “Suspecting and Testing for α-1 antitrypsin deficiency-an allergist's and/or immunologist's perspective,” The Journal of Allergy and Clinical Immunology. In Practice, vol. 3, no. 4, pp. 506–511, 2015. View at Publisher · View at Google Scholar
  11. B. PopŁawska, S. Janciauskiene, and J. Chorostowska-Wynimko, “Genetic variants of alpha-1 antitrypsin: classification and clinical implications,” Pneumonologia i Alergologia Polska, vol. 81, no. 1, pp. 45–54, 2013. View at Google Scholar · View at Scopus
  12. M. Y. Pervakova, V. L. Emanuel, E. A. Surkova et al., “Comparison of electrophoresis, immunoturbidimetric measurement and phenotyping of alpha-1-antitrypsin for the diagnosis of alpha-1-antitrypsin deficiency,” Kliniceskaja Laboratornaja Diagnostika, vol. 10, pp. 28–31, 2015. View at Google Scholar
  13. M. Y. Pervakova, S. V. Lapin, A. L. Chudinov et al., “Laboratory detection of α-1-antitrypsin deficiency in patients suffering from chronical lung pathology,” Modern Laboratory, vol. 18, no. 259, pp. 32–37, 2015. View at Google Scholar
  14. J.-O. Jeppsson, B. Franzen, and D. Wilson Cox, “Typing of genetic variants of α1-antitrypsin by electrofocusing,” Clinical Chemistry, vol. 28, no. 1, pp. 219–225, 1982. View at Google Scholar · View at Scopus
  15. D. N. Greene, M. C. Elliott-Jelf, J. A. Straseski, and D. G. Grenache, “Facilitating the laboratory diagnosis of α1-antitrypsin deficiency,” American Journal of Clinical Pathology, vol. 139, no. 2, pp. 184–191, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. S. P. Berger, M. A. J. Seelen, P. S. Hiemstra et al., “Proteinase 3, the major autoantigen of Wegener's granulomatosis, enhances IL-8 production by endothelial cells in vitro,” Journal of the American Society of Nephrology, vol. 7, no. 5, pp. 694–701, 1996. View at Google Scholar · View at Scopus
  17. F. Grimminger, K. Hattar, C. Papavassilis et al., “Neutrophil activation by anti-proteinase 3 antibodies in Wegener's granulomatosis: role of exogenous arachidonic acid and leukotriene B4 generation,” Journal of Experimental Medicine, vol. 184, no. 4, pp. 1567–1572, 1996. View at Publisher · View at Google Scholar · View at Scopus
  18. D. R. Ralston, C. B. Marsh, M. P. Lowe, and M. D. Wewers, “Antineutrophil cytoplasmic antibodies induce monocyte IL-8 release: role of surface proteinase-3, α1-antitrypsin, and Fcγ receptors,” Journal of Clinical Investigation, vol. 100, no. 6, pp. 1416–1424, 1997. View at Publisher · View at Google Scholar · View at Scopus
  19. B. A. van de Wiel, K. M. Dolman, C. H. van der Meer-Gerritsen, C. E. Hack, A. E. G. K. Von Dem Borne, and R. Goldschmeding, “Interference of Wegener's granulomatosis autoantibodies with neutrophil Proteinase 3 activity,” Clinical and Experimental Immunology, vol. 90, no. 3, pp. 409–414, 1992. View at Google Scholar · View at Scopus
  20. J. M. Hernandez Perez, S. Fumero Garcia, and A. Alvarez Pio, “Successful alpha1-antitrypsin replacement therapy in a patient with alpha1-antitrypsin deficiency and granulomatosis with polyangiitis,” Rheumatology (Oxford), vol. 52, no. 4, pp. 755–757, 2013. View at Google Scholar